Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa in advanced breast cancer
NCT00632723Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gefitinib in breast cancer, sponsored by AstraZeneca. Started Apr 2001; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00632723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632723.